Rankings
▼
Calendar
FOLD FY 2023 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FOLD
Amicus Therapeutics, Inc.
$5B
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$399M
+21.3% YoY
Gross Profit
$362M
90.7% margin
Operating Income
-$77M
-19.3% margin
Net Income
-$152M
-38.0% margin
EPS (Diluted)
$-0.51
Cash Flow
Operating Cash Flow
-$69M
Free Cash Flow
-$77M
Stock-Based Comp.
$86M
Balance Sheet
Total Assets
$778M
Total Liabilities
$618M
Stockholders' Equity
$160M
Cash & Equivalents
$247M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$399M
$329M
+21.3%
Gross Profit
$362M
$291M
+24.6%
Operating Income
-$77M
-$212M
+63.6%
Net Income
-$152M
-$237M
+35.9%
← Q4 2022
All Quarters
Q1 2023 →